000 | 01743 a2200445 4500 | ||
---|---|---|---|
005 | 20250517231941.0 | ||
264 | 0 | _c20181211 | |
008 | 201812s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2018.07.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRavula, Abhigyan | |
245 | 0 | 0 |
_aSimultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant. _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cOct 2018 |
||
300 |
_a119-125 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCannabidiol _xblood |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDronabinol _xblood |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aLimit of Detection |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aRimonabant _xadministration & dosage |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
650 | 0 | 4 | _aTobacco Smoke Pollution |
700 | 1 | _aChandasana, Hardik | |
700 | 1 | _aSetlow, Barry | |
700 | 1 | _aFebo, Marcelo | |
700 | 1 | _aBruijnzeel, Adriaan W | |
700 | 1 | _aDerendorf, Hartmut | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 160 _gp. 119-125 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2018.07.004 _zAvailable from publisher's website |
999 |
_c28700800 _d28700800 |